Marshall Glesby, M.D., Ph.D.

Infectious Disease

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

I spend the majority of my time conducting clinical research related to complications of HIV disease and its treatment. In addition to my HIV research, I collaborate with colleagues in Salvador, Brazil on investigations of tropical diseases, including leishmaniasis and HTLV-I infection. I have been privileged to work with and mentor medical students, residents, and infectious disease fellows on various research projects over the past decade. I also provide longitudinal care to HIV-infected patients at the Center for Special Studies, attend on the infectious diseases consult service at the New York Presbyterian Hospital, and direct the Weill Cornell site of a federally funded consortium that trains clinicians in HIV management.

Biographical Info

Dr. Marshall Glesby is Associate Chief of the Division of Infectious Diseases and Director of the Cornell HIV Clinical Trials Unit at the Weill Cornell Medical College. He is a graduate of the Johns Hopkins University School of Medicine and completed his internal medicine residency and infectious diseases fellowship at the Johns Hopkins Hospital. He also has a Ph.D. in Clinical Investigation from the Johns Hopkins School of Hygiene and Public Health and is board certified in internal medicine and infectious diseases. Dr. Glesby's primary research focus is metabolic complications of HIV disease and its therapy. He is active in the NIH-sponsored AIDS Clinical Trials Group (ACTG) and has served as Vice Chair of their Hepatitis Committee and a member of the ACTG Scientific Agenda Steering Committee. He is also the Regional Clinical Director of the federally funded New York/New Jersey AIDS Education and Training Center (AETC) and the medical director of the Weill Cornell AETC site of this consortium.

Dr. Glesby co-directs the Clinical Trials Design and Analysis course of the Weill Cornell K30 funded Masters in Clinical Investigation program. He serves on the Weill Cornell Clinical & Translational Science Center's Adult Translational Research Advisory Committee and their Multidisciplinary Institutional Advisory Committee. He is an Assistant Editor of the Journal of Acquired Immune Deficiency Syndromes. He also serves on the Weill Cornell Data Safety Monitoring Board (DSMB) and was a member of the Food and Drug Administration's Antiviral Drugs Advisory Committee.

Honors and Awards

2003: John E. Carey Young Investigator Award, Adult AIDS Clinical Trials Group.

2010: Excellence in Training Award, New York/New Jersey AIDS Education and Training Center

2011: HIV Research Award, HIV Medicine Association/Infectious Diseases Society of America

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Infectious Disease)
Clinical Expertise
AIDS (Acquired Immune Deficiency Syndrome)
HIV (Human Immunodeficiency Virus Infection)
  • Ph.D.
    The Johns Hopkins University School of Hygiene and Public Health
  • M.D.
    The Johns Hopkins University School of Medicine
  • Attending Physician
    NewYork-Presbyterian Hospital
  • Professor of Medicine
    Weill Cornell Medical College, Cornell University
  • Professor of Population Health Sciences
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Proprietary Interest: 
UpToDate, Inc.